Financials
- Market Capitalization 462.43 M
- Employee 88
- Founded 1994
- CEO Craig A Tooman
- Website www.silence-therapeutics.com
- Headquarter United Kingdom
- FIGI BBG00WVTHPN2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.65
ratio cours/chiffre d'affaires
1 541.15
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2985 | OVID Ovid Therapeutics Inc. - Common Stock | 2.45 USD | +0.82% | -11.23% | +7.93% | +512.50% | 457.27 M USD | ||
| 2989 | BNTC Benitec Biopharma Inc. - Common Stock | 12.99 USD | 0.00% | -3.35% | +14.25% | -21.79% | 446.26 M USD | ||
| 3000 | VALN Valneva SE - American Depositary Shares | 5.14 USD | -2.28% | -2.28% | -6.03% | -21.29% | 446.00 M USD | ||
| 3010 | EVMN Evommune, Inc. Common Stock | 12.00 USD | -0.91% | -8.33% | -40.06% | -30.72% | 432.22 M USD |